Lisa Jarvis: Alzheimer's drug gets FDA nod but hurdles remain | World & Nation
Eisai Co. and Biogen Inc.’s Alzhiemer’s drug Leqembi has been granted full approval by the Food and Drug Administration, making it the first disease-slowing drug to secure that full blessing.